Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cytotoxic Drug”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT00039091
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung Cancer

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+11 more
National Cancer Institute (NCI) 26
Not applicableStudy completedNCT04253080
What this trial is testing

Expression of IL4 Induced Gene 1 in Patients With Cutaneous Melanoma: Value in Prognosis and/or in Predictive Response to Immune Checkpoint Inhibitors

Who this might be right for
Cutaneous Melanoma
Assistance Publique - Hôpitaux de Paris 127
Early research (Phase 1)Study completedNCT01070797
What this trial is testing

Administration of Rapidly Generated Multivirus-specific Cytotoxic T-Lymphocytes (VIRAGE)

Who this might be right for
Adenovirus InfectionEpstein-Barr Virus InfectionsCytomegalovirus Infections+1 more
Baylor College of Medicine 10
Not applicableLooking for participantsNCT06911970
What this trial is testing

Impact of Aerobic Exercise on the Anticancer Immune Response in Patients Receiving Cancer Treatment

Who this might be right for
Colorectal CancerBreast CancerNon Metastatic Cancer
Université de Sherbrooke 44
Large-scale testing (Phase 3)Study completedNCT02264990
What this trial is testing

Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Adults Receiving First Cytotoxic Chemotherapy for Metastatic or Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC) and Who Are Current or Former Smokers

Who this might be right for
Non-squamous Non-small Cell Lung Cancer
AbbVie 595
Large-scale testing (Phase 3)Study completedNCT00686959
What this trial is testing

Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Eli Lilly and Company 598
Testing effectiveness (Phase 2)Study completedNCT02878785
What this trial is testing

Decitabine and Talazoparib in Untreated AML and R/R AML

Who this might be right for
Acute Myeloid Leukemia
University of Maryland, Baltimore 25
Early research (Phase 1)Not Yet RecruitingNCT07691450
What this trial is testing

Belinostat in Combination With Azacitidine or Pralatrexate for the Treatment of Relapse or Refractory T-cell Lymphoma

Who this might be right for
Recurrent Anaplastic Large Cell LymphomaRecurrent Enteropathy-Associated T-Cell LymphomaRecurrent Follicular Helper T-Cell Lymphoma+23 more
City of Hope Medical Center 40
Early research (Phase 1)Ended earlyNCT00383097
What this trial is testing

Lmp1 and Lmp2 Specific CTLs Following Cd45 Antibody for Relapsed Ebv-Positive Hodgkin's Or Non-Hodgkin's Lymphoma

Who this might be right for
Hodgkins LymphomaNon-Hodgkin Lymphoma
Baylor College of Medicine 6
Not applicableStudy completedNCT07182903
What this trial is testing

Fatigue in MS: From Invisible to Measurable

Who this might be right for
Multiple Sclerosis
University Medical Center Groningen 34
Large-scale testing (Phase 3)Study completedNCT05220878
What this trial is testing

Comparative Study of Clinical Efficacy and Safety of GNR-069 and Nplate in Patients With ITP

Who this might be right for
Idiopathic Thrombocytopenic Purpura
AO GENERIUM 160
Large-scale testing (Phase 3)Temporarily pausedNCT05691478
What this trial is testing

Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

Who this might be right for
High Grade OsteosarcomaLocalized OsteosarcomaMetastatic Osteosarcoma+1 more
National Cancer Institute (NCI) 1,122
Large-scale testing (Phase 3)UnknownNCT00516425
What this trial is testing

Doxorubicin or Epirubicin and Cyclophosphamide in Treating Older Women With Invasive Breast Cancer

Who this might be right for
Breast Cancer
Charing Cross Hospital 1,000
Not applicableAvailableNCT07104591
What this trial is testing

TETRAVI Expanded Access Program

Who this might be right for
Epstein-Barr Virus InfectionCytomegalovirus InfectionsAdenovirus Infection+4 more
Baylor College of Medicine
Not applicableLooking for participantsNCT04053439
What this trial is testing

Clonal Hematopoiesis is a Risk Factor for Chemotherapy-Related Complications

Who this might be right for
LymphomaChemotherapeutic Toxicity
Sunnybrook Health Sciences Centre 188
Testing effectiveness (Phase 2)Ended earlyNCT02076243
What this trial is testing

Treatment With Nab-paclitaxel in Cutaneous SCC

Who this might be right for
Cutaneous Squamous Cell Carcinoma
Icahn School of Medicine at Mount Sinai 2
Testing effectiveness (Phase 2)WithdrawnNCT01409187
What this trial is testing

IPI-Biotherapy for Patients Previously Treated With Cytotoxic Drugs With Metastatic Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center
Large-scale testing (Phase 3)Ended earlyNCT02322281
What this trial is testing

TIGER-3: Open Label, Multicenter Study of Rociletinib (CO-1686) Mono Therapy Versus Single-agent Cytotoxic Chemotherapy in Patients With Mutant EGFR NSCLC Who Have Failed at Least One Previous EGFR-Directed TKI and Platinum-doublet Chemotherapy

Who this might be right for
Non-small Cell Lung Cancer
Clovis Oncology, Inc. 149
Early research (Phase 1)Study completedNCT02555397
What this trial is testing

Phase 1 Trial of Interleukin 12 Gene Therapy for Locally Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
Henry Ford Health System 15
Testing effectiveness (Phase 2)Ended earlyNCT04319224
What this trial is testing

Vopratelimab (JTX-2011) Alone and in Combination With Anti-Programmed Cell Death Protein 1 (PD-1) or Anti-Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4) in Subjects With Advanced and/or Refractory Solid Tumors

Who this might be right for
Cancer
Jounce Therapeutics, Inc. 4
Next Page